The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

For its next game, Elden Ring Nightreign, FromSoftware is going all-in on the bosses. This roguelike-ish co-op game is fully combat focused, with each of Nightreign’s runs pitting players against an ...